share_log

Autolus Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BXLS V – Autobahn L.P.(14.0%),Blackstone Life Sciences Associates V (CYM) L.L.C.(14.0%), etc.

Autolus Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-BXLS V – Autobahn L.P.(14.0%),Blackstone Life Sciences Associates V (CYM) L.L.C.(14.0%)等

2022/12/13 16:51
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息